David Shaw’s Icosavax, Inc. Common Stock ICVX Stock Holding History

David Shaw’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,715	Closed	-$374K	–	4896
2023 Q4	$374K	Buy	+23,715	New	+$228K	﹤0.01%	3658
2022 Q4	–	Sell	-74,000	Closed	-$234K	–	5248
2022 Q3	$234K	Buy	74,000 +3,245	+5%	+$20.3K	﹤0.01%	4408
2022 Q2	$405K	Sell	70,755 -18,427	-21%	-$144K	﹤0.01%	4220
2022 Q1	$628K	Buy	89,182 +67,409	+310%	+$1.06M	﹤0.01%	4230
2021 Q4	$498K	Buy	21,773 +2,266	+12%	+$58.5K	﹤0.01%	4406
2021 Q3	$577K	Buy	+19,507	New	+$661K	﹤0.01%	4005

David Shaw's ICVX Position: Q1 2024 in Review

David Shaw sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 23,715 shares — an estimated $374K sold.

David Shaw first reported a position in ICVX in Q3 2021 and held it in 6 quarters. The position peaked at $628K in Q1 2022. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

David Shaw reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
David Shaw sold 23,715 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $374K.
David Shaw first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
David Shaw's Icosavax, Inc. Common Stock position peaked at $628K in Q1 2022.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.